Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma-Reference-Cited by-同舟云学术

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma

Published:2019-09 Issue:9 Volume:25 Page:1703-1712
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

López-Corral Lucia,Caballero-Velázquez Teresa,López-Godino Oriana,Rosiñol Laura,Pérez-Vicente Sabina,Fernandez-Avilés Francesc,Krsnik Isabel,Morillo Daniel,Heras Inmaculada,Morgades Mireia,Rifon Jose J.,Sampol Antonia,Iniesta Francisca,Ocio Enrique-María,Martin Jesús,Rovira Montserrat,Cabero Martín,Castilla-Llorente Cristina,Ribera Josep-María,Torres-Juan Marta,Moraleda Jose María,Martinez Carmen,Vázquez Alejandro,Gutierrez Gonzalo,Caballero Dolores,San Miguel Jesús F.,Mateos María-Victoria,Pérez-Simón Jose Antonio

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma;Lokhorst;J Clin Oncol,2010

2. Treatment of multiple myeloma;Barlogie;Blood,2004

3. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning—evidence for a superior outcome using melphalan combined with total body irradiation;Hunter;Br J Haematol,2005

4. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma;Kröger;Biol Blood Marrow Transplant,2013

5. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience;Cancers;2023-12-07

3. Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma;Frontiers in Oncology;2022-01-05

4. Allogeneic Stem Cell Transplantation in Multiple Myeloma;Cancers;2021-12-23

5. The Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma: A Systematic Review of the Literature;Cureus;2021-09-27